What is the recommended management algorithm for a hemodynamically stable patient with regular narrow‑complex supraventricular tachycardia?

Management Algorithm for Hemodynamically Stable SVT

For hemodynamically stable patients with regular narrow-complex SVT, begin immediately with vagal maneuvers (particularly the modified Valsalva technique), followed by intravenous adenosine if vagal maneuvers fail, and reserve synchronized cardioversion for cases where pharmacological therapy is ineffective or contraindicated. 1

Step-by-Step Treatment Algorithm

First-Line: Vagal Maneuvers

Vagal maneuvers should be your immediate first intervention and must be performed with the patient in the supine position 1:

• Modified Valsalva maneuver: Patient bears down against a closed glottis for 10-30 seconds, generating at least 30-40 mm Hg of intrathoracic pressure. This is more successful than carotid massage 1
• Carotid sinus massage: After confirming absence of carotid bruit by auscultation, apply steady pressure over the right or left carotid sinus for 5-10 seconds 1
• Ice-water facial immersion: Apply ice-cold wet towel to face, or facial immersion in 10°C water (diving reflex) 1
• Success rate: Approximately 28% when switching between techniques, with Valsalva superior to carotid massage 1

Critical pitfall: Never apply pressure to the eyeball—this is dangerous and abandoned 1

Second-Line: Intravenous Adenosine

If vagal maneuvers fail, adenosine is the drug of choice 1:

• Efficacy: Terminates AVNRT in approximately 95% of patients and orthodromic AVRT in 90-95% 1
• Dual role: Both therapeutic and diagnostic—will unmask atrial activity in atrial flutter or atrial tachycardia 1
• Side effects: Minor and brief (<1 minute) in approximately 30% of patients 1

Critical warnings with adenosine:

• May precipitate atrial fibrillation that could conduct rapidly and cause ventricular fibrillation—have cardioversion equipment ready 1
• Patients often have premature complexes immediately after conversion that may reinitiate tachycardia—may require antiarrhythmic drug to prevent recurrence 1

Third-Line: Alternative IV Medications (If Adenosine Fails)

Intravenous calcium channel blockers or beta-blockers are reasonable alternatives 1:

• IV diltiazem or verapamil: Particularly effective for converting AVNRT to sinus rhythm with success rates of 80-98% 1
• IV beta-blockers: Reasonable option with excellent safety profile, though diltiazem is more effective 1

Absolute contraindications for calcium channel blockers/beta-blockers:

• Do NOT use if ventricular tachycardia or pre-excited atrial fibrillation is possible—can cause hemodynamic collapse and ventricular fibrillation 1
• Avoid in suspected systolic heart failure 1
• Must ensure narrow-complex SVT diagnosis before administration

Fourth-Line: Synchronized Cardioversion

Proceed to synchronized cardioversion when pharmacological therapy fails or is contraindicated 1:

• Highly effective for terminating SVT (including AVRT and AVNRT) 1
• Perform after adequate sedation or anesthesia in stable patients 1
• In rare resistant cases, a second drug bolus or higher dose may be attempted before cardioversion 1

Important Guideline Updates (2019 ESC)

The 2019 ESC guidelines made significant changes to SVT management 2:

Upgraded recommendations:

• Adenosine strengthened for acute management
• Beta-blockers upgraded for narrow-QRS tachycardias

Downgraded/no longer recommended:

• Verapamil and diltiazem downgraded from previous guidelines
• Amiodarone and digoxin no longer recommended for acute narrow-QRS tachycardias
• Sotalol and lidocaine no longer recommended for wide-QRS tachycardias

Key Clinical Pearls

Documentation is essential: Obtain 12-lead ECG during tachycardia before treatment when possible—identifies P waves, P-to-QRS relationship, and confirms narrow-complex morphology 1

Oral medications: Oral beta-blockers, diltiazem, or verapamil may be reasonable in stable patients without IV access, though evidence is limited 1

Last resort: IV amiodarone may be considered only when other therapies are ineffective or contraindicated 1

Definitive management: Catheter ablation is first-line therapy for preventing recurrence, with single-procedure success rates of 94.3-98.5% 3